Core Scientific, Inc. (NASDAQ:CORZ - Free Report) - Equities researchers at Roth Capital lifted their FY2027 earnings per share (EPS) estimates for shares of Core Scientific in a research report issued to clients and investors on Monday, December 16th. Roth Capital analyst D. Aftahi now expects that the company will earn $0.95 per share for the year, up from their prior forecast of $0.88. Roth Capital has a "Strong-Buy" rating on the stock. The consensus estimate for Core Scientific's current full-year earnings is $0.50 per share. Roth Capital also issued estimates for Core Scientific's FY2028 earnings at $2.49 EPS.
Several other research analysts have also commented on the stock. Canaccord Genuity Group restated a "buy" rating and issued a $17.00 price objective on shares of Core Scientific in a report on Thursday, November 7th. Canaccord Genuity Group began coverage on shares of Core Scientific in a research note on Monday, September 23rd. They issued a "buy" rating and a $16.00 price target for the company. Needham & Company LLC lifted their price objective on Core Scientific from $17.00 to $18.00 and gave the company a "buy" rating in a research report on Thursday, November 7th. BTIG Research increased their target price on Core Scientific from $19.00 to $20.00 and gave the stock a "buy" rating in a research report on Monday. Finally, Compass Point raised their target price on Core Scientific from $18.00 to $20.00 and gave the company a "buy" rating in a research note on Wednesday, October 23rd. Thirteen research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Buy" and an average price target of $18.46.
Check Out Our Latest Analysis on CORZ
Core Scientific Stock Performance
Shares of Core Scientific stock traded down $0.53 during midday trading on Tuesday, reaching $16.03. 10,667,969 shares of the company's stock traded hands, compared to its average volume of 9,075,139. The company has a market cap of $4.48 billion and a PE ratio of -2.96. The stock has a 50 day moving average of $15.17 and a 200-day moving average of $11.83. Core Scientific has a 12 month low of $2.61 and a 12 month high of $18.63.
Insider Buying and Selling
In other news, insider Todd M. Duchene sold 25,000 shares of the business's stock in a transaction on Wednesday, November 20th. The stock was sold at an average price of $17.10, for a total value of $427,500.00. Following the completion of the transaction, the insider now owns 1,661,474 shares in the company, valued at $28,411,205.40. The trade was a 1.48 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Yadin Rozov sold 105,000 shares of the stock in a transaction on Friday, November 22nd. The shares were sold at an average price of $18.11, for a total value of $1,901,550.00. Following the sale, the director now directly owns 345,239 shares in the company, valued at $6,252,278.29. This trade represents a 23.32 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 32.00% of the stock is currently owned by company insiders.
Institutional Inflows and Outflows
Hedge funds have recently made changes to their positions in the stock. P Schoenfeld Asset Management LP purchased a new stake in Core Scientific during the second quarter valued at $4,185,000. Highland Peak Capital LLC increased its position in shares of Core Scientific by 37.9% during the 3rd quarter. Highland Peak Capital LLC now owns 413,584 shares of the company's stock valued at $4,905,000 after purchasing an additional 113,584 shares during the last quarter. Mirabella Financial Services LLP bought a new position in shares of Core Scientific in the 3rd quarter worth approximately $18,383,000. Van ECK Associates Corp lifted its stake in shares of Core Scientific by 22.9% in the 3rd quarter. Van ECK Associates Corp now owns 1,616,944 shares of the company's stock worth $19,177,000 after purchasing an additional 300,942 shares during the period. Finally, DeepCurrents Investment Group LLC boosted its holdings in shares of Core Scientific by 157.7% in the second quarter. DeepCurrents Investment Group LLC now owns 255,162 shares of the company's stock worth $2,373,000 after buying an additional 156,162 shares during the last quarter.
About Core Scientific
(
Get Free Report)
Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.
See Also
Before you consider Core Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Core Scientific wasn't on the list.
While Core Scientific currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.